162 related articles for article (PubMed ID: 2767528)
1. A phase II evaluation of cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Bonomi P; Blessing J; Ball H; Hanjani P; DiSaia PJ
Gynecol Oncol; 1989 Sep; 34(3):357-9. PubMed ID: 2767528
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Gershenson DM; McGehee R
J Clin Oncol; 1999 Sep; 17(9):2676-80. PubMed ID: 10561341
[TBL] [Abstract][Full Text] [Related]
3. A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: a Southwest Oncology Group trial.
Weiss GR; Green S; Hannigan EV; Boutselis JG; Surwit EA; Wallace DL; Alberts DS
Gynecol Oncol; 1990 Jun; 37(3):354-8. PubMed ID: 2351319
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Mannel RS; Blessing JA; Boike G
Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.
Fiorica J; Holloway R; Ndubisi B; Orr J; Grendys E; Boothby R; DeCesare S; LaPolla J; Hoffman M; Patel J
Gynecol Oncol; 2002 Apr; 85(1):89-94. PubMed ID: 11925125
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of bolus cis-platinum and continuous 5-fluorouracil infusion for metastatic and recurrent squamous cell carcinoma of the cervix.
Rotmensch J; Senekjian EK; Javaheri G; Herbst AL
Gynecol Oncol; 1988 Jan; 29(1):76-81. PubMed ID: 3338666
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy of advanced squamous carcinoma of the cervix: a phase I-II study of high-dose cisplatin and cyclophosphamide. A pilot study of the Gynecologic Oncology Group.
Jobson VW; Muss HB; Thigpen JT; Homesley HD; Bundy B
Am J Clin Oncol; 1984 Aug; 7(4):341-5. PubMed ID: 6540048
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.
Kim S; François E; André T; Samalin E; Jary M; El Hajbi F; Baba-Hamed N; Pernot S; Kaminsky MC; Bouché O; Desrame J; Zoubir M; Ghiringhelli F; Parzy A; De La Fouchardiere C; Smith D; Deberne M; Spehner L; Badet N; Adotevi O; Anota A; Meurisse A; Vernerey D; Taieb J; Vendrely V; Buecher B; Borg C
Lancet Oncol; 2018 Aug; 19(8):1094-1106. PubMed ID: 30042063
[TBL] [Abstract][Full Text] [Related]
10. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Van Le L; Waggoner S
Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
[TBL] [Abstract][Full Text] [Related]
11. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
[TBL] [Abstract][Full Text] [Related]
12. [Systemic therapy in recurrent and primary advanced cervix cancer].
Kaufmann M; Schmid H; Junkermann H; Schönig T; von Fournier D; Bastert G
Geburtshilfe Frauenheilkd; 1991 Jun; 51(6):454-62. PubMed ID: 1716240
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.
Omura GA; Blessing JA; Vaccarello L; Berman ML; Clarke-Pearson DL; Mutch DG; Anderson B
J Clin Oncol; 1997 Jan; 15(1):165-71. PubMed ID: 8996138
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
Muggia FM; Blessing JA; McGehee R; Monk BJ
Gynecol Oncol; 2004 Aug; 94(2):483-7. PubMed ID: 15297192
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of carboplatin and cisplatin in advanced or recurrent squamous carcinoma of the uterine cervix.
Morris M; Gershenson DM; Burke TW; Mitchell MF; Levenback C; Atkinson N; Wharton JT
Gynecol Oncol; 1994 May; 53(2):234-8. PubMed ID: 8188085
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
[TBL] [Abstract][Full Text] [Related]
18. A phase II study of ifosfamide and cisplatin chemotherapy for metastatic or relapsed carcinoma of the cervix.
Coleman RE; Clarke JM; Slevin ML; Sweetenham J; Williams CJ; Blake P; Calman F; Wiltshaw E; Harper PG
Cancer Chemother Pharmacol; 1990; 27(1):52-4. PubMed ID: 2245492
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A.
Sundfør K; Tropé CG; Högberg T; Onsrud M; Koern J; Simonsen E; Bertelsen K; Westberg R
Cancer; 1996 Jun; 77(11):2371-8. PubMed ID: 8635109
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of cisplatin plus decitabine, a new DNA hypomethylating agent, in patients with advanced squamous cell carcinoma of the cervix.
Pohlmann P; DiLeone LP; Cancella AI; Caldas AP; Dal Lago L; Campos O; Monego E; Rivoire W; Schwartsmann G
Am J Clin Oncol; 2002 Oct; 25(5):496-501. PubMed ID: 12393992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]